Inpixon Reports Third Quarter 2020 Financial Results and Provides Corporate Update

PALO ALTO, Calif., Nov. 12, 2020 /PRNewswire/ -- Inpixon (Nasdaq: INPX), the Indoor Intelligence(TM) company, today provided a business update and reported financial results for the third quarter of 2020.

Recent Milestones:

    --  Acquired Nanotron, a global location awareness technology company; Oct.
        2020 acquisition increases revenue and is expected to be accretive to
        earnings
    --  Acquired "blue dot" on-device positioning technology and intellectual
        property assets in Aug. 2020, expanding Inpixon's Indoor Intelligence
        capabilities on mobile devices
    --  Acquired an exclusive global distribution and development license for
        SYSTAT and SigmaPlot software suite of products in June 2020;
        acquisition increases revenue and is expected to be accretive to
        earnings
    --  Inpixon RF Video Connector integrated into Genetec Security Center
        Omnicast for sensor fusion-enabled video analytics
    --  Participated in CNN-moderated "Reclaim Your Workplace: Creating a
        Resilient Environment Post-Pandemic" roundtable
    --  Expanded Latin American reach -- executed sales and distribution
        agreement with importer and distributor, GASCOM
    --  Inpixon and FSI team for facility management solutions incorporating
        intelligent maps to combat COVID-19
    --  Inpixon and The CXApp collaborate on desk-booking and enterprise campus
        apps plus multi-technology social distancing and contact tracing
        methodologies designed to reduce COVID-19 infections and enhance
        incident response
    --  Received FCC certification for ultra-wideband (UWB) module

Nadir Ali, CEO of Inpixon, commented, "This has been a productive quarter, to say the least. In the beginning of the year, we set out a goal to grow our business in terms of revenue and to continue the path of innovation we initiated last year in order to develop the most comprehensive, intelligent platform available in the market for Indoor Intelligence. By successfully completing a number of key acquisitions, in 2020 we increased our technical advantage by adding key capabilities, such as on-device positioning, which can be leveraged by device users to understand where they are within a building, and two-way ranging, allowing for the measurement of distance between two devices. We also acquired best-in-class UWB technology, permitting finer, more precise positioning capabilities down to 30 cm with the acquisition of Nanotron Technologies GmbH, a market leader in UWB technologies.

"With the transactions completed this year, we expanded our operations to Europe, as well as our customer base internationally in Europe, Asia, Africa, South America and the Middle East, and our partner relationships with marquee distribution and technology partners. We have expanded our reach to new verticals such as mine safety, livestock and manufacturing, and added additional use cases such as collision avoidance, safety zones and RTLS. We also strengthened our intellectual property portfolio by acquiring a number of patents, trademarks and other rights.

"Even during an unprecedented year of challenges faced by people and businesses throughout the world, Inpixon has transformed as an organization, becoming financially and operationally stronger. We have expanded our technological capabilities and product offerings as a premier provider of Indoor Intelligence solutions with the ability to offer our customers insights about their spaces that we believe far exceed our competitors. Importantly, we have become a one-stop solution for Indoor Intelligence. Rather than only selling products or services to address a single issue or as part of a total solution typically requiring the integration of offerings by multiple vendors, we can provide a comprehensive solution to address certain key pain points of our customers. We are approaching global enterprises, including some well-known Fortune 500 companies, offering what we believe is unparalleled Indoor Intelligence capabilities under one roof to address safety and security concerns, increase operational efficiencies and improve their bottom line. We believe this approach has resonated extremely well among customers, partners, distributors and resellers.

"With approximately $31.4 million of cash as of September 30, 2020, we believe we are well positioned for continued growth and have the flexibility to execute on our growth strategy. We are focused on creating long-term shareholder value, and in 2020 we concentrated on continuing to enhance and expand our capabilities to be a single-source provider of premier Indoor Intelligence solutions. Our efforts are aimed at scaling the business both organically and through M&A, and I'm confident that despite the challenges of this year with COVID-19, our growth strategy is working as indicated by the 66% increase in revenue for the third quarter ended September 30, 2020, compared to the same period last year. This growth reflects a recovery back to the growth rates we were achieving prior to the shelter-in-place directives we had to contend with in Q2 2020, and I expect this growth trend to continue in Q4 2020."

Financial Results

Revenues for the third quarter ended September 30, 2020 were $2.55 million compared to $1.53 million for the comparable period in the prior year for an increase of $1.02 million or approximately 66%. The increase in revenues was primarily attributable to an increase in sales in our Aware and Mapping product lines and the addition of sales from the new Systat licensing product line. Gross profit for the three months ended September 30, 2020 was $1.9 million compared to $1.2 million for the comparable period in the prior year, an increase of 66%. The gross profit margin for the three months ended September 30, 2020 and 2019 was 75%. Net loss attributable to stockholders of Inpixon for the three months ended September 30, 2020 was $7.5 million compared to a net loss of $6.6 million for the comparable period in the prior year. The higher loss of approximately $0.9 million was primarily attributable the higher operating expenses offset by the increased revenue during the three months ended September 30, 2020. Non-GAAP Adjusted EBITDA for the three months ended September 30, 2020 was a loss of $4.6 million compared to a loss of $2.4 million for the prior period in 2019. EBITDA is defined as net income (loss) before interest, provision for income taxes, and depreciation and amortization. Adjusted EBITDA is used by Inpixon management as a metric by which it manages the business. It is defined as EBITDA plus adjustments for other income or expense items, non-recurring items and other non-cash items including stock-based compensation.

Proforma non-GAAP net loss per basic and diluted common share for the three months ended September 30, 2020 was a loss of $0.13 per share compared to a loss of $7.44 per share for the prior period in 2019. Proforma non-GAAP net income (loss) per share is used by the Company's management as an evaluation tool as it manages the business and is defined as net income (loss) per basic and diluted share adjusted for stock based compensation, amortization of intangibles, provision for doubtful accounts, severance costs, acquisition costs, costs associated with public offerings and one time charges including loss on the exchange of debt for equity and provision for valuation allowances.

Conference Call

Management will host a conference call at 4:30 p.m. Eastern Time on Thursday, November 12, 2020 to discuss the Company's financial results for the third quarter ended September 30, 2020 as well as the Company's corporate progress and other developments.

The conference call will be available via telephone by dialing toll free 866-342-8591 for U.S. callers or +1 203-518-9713 for international callers, or on the Company's Investors section of the website: ir.inpixon.com.

A webcast replay will be available on the Company's Investors section of the website (ir.inpixon.com) through February 12, 2021. A telephone replay of the call will be available approximately one hour following the call, through November 19, 2020 and can be accessed by dialing 877-481-4010 for U.S. callers or +1 919-882-2331 for international callers and entering conference ID: 38565.

About Inpixon

Inpixon® (Nasdaq: INPX) is the Indoor Intelligence(TM) company that specializes in capturing, interpreting and giving context to indoor data so it can be translated into actionable intelligence. The company's Indoor Intelligence platform ingests diverse data from IoT, third-party and proprietary sensors designed to detect and position active cellular, Wi-Fi, UWB and Bluetooth devices. Paired with a high-performance data analytics engine, patented algorithms, and advanced mapping technology, Inpixon's solutions are leveraged by a multitude of industries to do good with indoor data. This multidisciplinary depiction of indoor data enables users to increase revenue, decrease costs, and enhance safety. Inpixon customers can boldly take advantage of location awareness, analytics, sensor fusion and the Internet of Things (IoT) to uncover the untold stories of the indoors. For the latest insights, follow Inpixon on LinkedIn, Twitter, and visit inpixon.com.

Safe Harbor Statement

All statements in this release that are not based on historical fact are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 and the provisions of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. While management has based any forward-looking statements included in this release on its current expectations, the information on which such expectations were based may change. These forward-looking statements rely on a number of assumptions concerning future events and are subject to a number of risks, uncertainties and other factors, many of which are outside of the control of Inpixon and its subsidiaries, which could cause actual results to materially differ from such statements. Such risks, uncertainties, and other factors include, but are not limited to, the fluctuation of economic conditions, the impact of COVID-19 on Inpixon's results of operations, our ability to integrate the businesses we acquire into our existing business, the performance of management and employees, the regulatory landscape as it relates to privacy regulations and their applicability to Inpixon's technology, Inpixon's ability to maintain compliance with Nasdaq's minimum bid price requirement and other continued listing requirements, including during a panel monitoring period ending on February 5, 2021, the ability to obtain financing, competition, general economic conditions and other factors that are detailed in Inpixon's periodic and current reports available for review at sec.gov. Furthermore, Inpixon operates in a highly competitive and rapidly changing environment where new and unanticipated risks may arise. Accordingly, investors should not place any reliance on forward-looking statements as a prediction of actual results. Inpixon disclaims any intention to, and undertakes no obligation to, update or revise forward-looking statements.

Non-GAAP Financial Measures

Management believes that certain financial measures not in accordance with generally accepted accounting principles in the United States ("GAAP") are useful measures of operations. EBIDTA, Adjusted EBITDA and pro forma net loss per share are non-GAAP measures. Inpixon defines "EBITDA" as net income (loss) before interest, provision for (benefit from) income taxes, and depreciation and amortization. Management uses Adjusted EBITDA as the matrix in which it manages the business and Inpixon defines "Adjusted EBITDA" as EBITDA plus adjustments for deemed dividends, other income or expense items, non-recurring items and non-cash items. Inpixon defines "pro forma net loss per share" as GAAP net loss per share adjusted for deemed dividends, stock based compensation, amortization of intangibles, provision for doubtful accounts, severance costs, acquisition costs, costs associated with public offerings and one time charges including loss on the exchange of debt for equity and provision for valuation allowances.

Management provides Adjusted EBITDA and pro forma net loss per share measures so that investors will have the same financial information that management uses, which may assist investors in assessing Inpixon's performance on a period-over-period basis. Adjusted EBITDA or pro forma net loss per share is not a measure of financial performance under GAAP, and should not be considered an alternative to net income (loss) or any other measure of performance under GAAP, or to cash flows from operating, investing or financing activities as an indicator of cash flows or as a measure of liquidity. Adjusted EBITDA and pro forma net loss per share have limitations as analytical tools and should not be considered either in isolation or as a substitute for analysis of Inpixon's results as reported under GAAP.

For more information on our non-GAAP financial measures and a reconciliation of GAAP to non-GAAP measures, please see the "Reconciliation of Non-GAAP Financial Measures" table accompanying this press release.

Inpixon Contacts

Media relations and general inquiries:
Inpixon
Email: marketing@inpixon.com
Web: inpixon.com/contact-us

Investor relations:
Crescendo Communications, LLC
Tel: +1 212-671-1020
Email: INPX@crescendo-ir.com


                                                                 
            
              INPIXON AND SUBSIDIARIES


                                                          
            
               CONDENSED CONSOLIDATED BALANCE SHEETS


                                                      
      
              (In thousands, except number of shares and par value data)

                                                                                     ---



                                                        
            As of



                                                          September 30, 2020                                                  December 31, 2019



                                                              (Unaudited)                                                
            (Audited)



     
              ASSETS



     
              Current Assets



     Cash and cash equivalents                                                                   $
            31,376                               $
          4,777



     Accounts receivable, net                                                                               1,948                                       1,108



     Notes and other receivables                                                                              378                                          74



     Inventory                                                                                                414                                         400


      Prepaid assets and other current assets                                                                1,144                                         406




     
              Total Current Assets                                                                       35,260                                       6,765





     Property and equipment, net                                                                              553                                         145


      Operating lease right-of-use asset,
       net                                                                                                   1,622                                       1,585



     Software development costs, net                                                                        1,729                                       1,544



     Intangible assets, net                                                                                10,761                                       8,400



     Goodwill                                                                                               2,555                                       2,070



     Receivable from related party                                                                                                                       616



     Other assets                                                                                             113                                          94




     
              Total Assets                                                                     $
            52,593                              $
          21,219





                 LIABILITIES AND STOCKHOLDERS' EQUITY



     
              Current Liabilities



     Accounts payable                                                                               $
            813                               $
          2,383



     Accrued liabilities                                                                                    1,914                                       1,863



     Operating lease obligation                                                                               572                                         776



     Deferred revenue                                                                                       1,842                                         912



     Short-term debt                                                                                        6,150                                       7,304



     Acquisition liability                                                                                    750                                         502



                 Total Current Liabilities                                                                  12,041                                      13,740




                 Long Term Liabilities


      Operating lease obligations, noncurrent                                                                1,074                                         837



     Other liabilities                                                                                          7                                           7


      Deferred tax liability, noncurrent                                                                                                                   87


      Acquisition liability, noncurrent                                                                                                                   500




     
              Total Liabilities                                                                          13,122                                      15,171




                 Commitments and Contingencies





     
              Stockholders' Equity


      Preferred Stock -$0.001 par value;
       5,000,000 shares authorized, consisting            2019, respectively.
       of Series 4 Convertible Preferred Stock
       -10,415 shares authorized; 1 and 1
       issued, and 1 and 1 outstanding as of
       September 30, 2020 and December 31,
       2019, respectively, Series 5
       Convertible Preferred Stock -12,000
       shares authorized; 126 and 126 issued,
       and 126 and 126 outstanding as of
       September 30, 2020 and December 31,


      Common Stock -$0.001 par value;
       250,000,000 shares authorized;
       42,259,314 and 4,234,923 issued and
       42,259,313 and  4,234,922 outstanding
       as of September 30, 2020 and December
       31, 2019, respectively.                                                                                  42                                           4



     Additional paid-in capital                                                                           212,913                                     158,382


      Treasury stock, at cost, 1 share                                                                       (695)                                      (695)


      Accumulated other comprehensive income                                                                 (130)                                         94


      Accumulated deficit (excluding $2,442
       reclassified to additional paid in
       capital in quasi-reorganization)                                                                  (172,710)                                  (151,763)



      Stockholders' Equity Attributable to
       Inpixon                                                                                              39,420                                       6,022





     Non-controlling interest                                                                                  51                                          26





                 Total Stockholders' Equity                                                                 39,471                                       6,048





                 Total Liabilities and Stockholders'
                  Equity                                                                          $
            52,593                              $
          21,219


                                                                                      
              
                INPIXON AND SUBSIDIARIES


                                                                       
              
         CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS


                                                                                    
          
                (In thousands, except per share data)

                                                                                                             ---



                                                       For the Three Months Ended                                       For the Nine Months Ended


                                                    
             September 30,                                  
              September 30,



                                                                             2020                                  2019                                     2020 2019



                                                     
             (Unaudited)                                   
              (Unaudited)



     
                Revenues                                                              $
              2,554                                    $
              1,534            $
          5,434     $
           4,387


                   Cost of Revenues                                                                    645                                                  382                    1,459              1,109





                   Gross Profit                                                                      1,909                                                1,152                    3,975              3,278




                   Operating Expenses


      Research and development                                                                       1,717                                                  926                    4,329              2,677



     Sales and marketing                                                                            1,703                                                  847                    3,862              2,161


      General and administrative                                                                     4,103                                                3,521                   10,371              9,890


      Acquisition related costs                                                                        344                                                  573                      540              1,220


      Amortization of intangibles                                                                      288                                                  969                    1,811              2,602



                   Total Operating Expenses                                                          8,155                                                6,836                   20,913             18,550





                   Loss from Operations                                                            (6,246)                                             (5,684)                (16,938)          (15,272)




                   Other Income (Expense)



     Interest expense, net                                                                          (537)                                             (1,190)                 (1,934)           (2,053)


      Provision for valuation allowance
       on held for sale loan                                                                         (679)                                                                     (1,514)


      Loss on exchange of debt for
       equity                                                                                                                                             (27)                   (132)             (188)



     Other income (expense)                                                                            11                                                  289                    (488)               518



                   Total Other Income (Expense)                                                    (1,205)                                               (928)                 (4,068)           (1,723)





                   Net Loss from Operations, before
                    tax                                                                            (7,451)                                             (6,612)                (21,006)          (16,995)



     Income tax benefit                                                                                                                                    33                       87                 35




     
                Net Loss                                                                        (7,451)                                             (6,579)                (20,919)          (16,960)





                   Net Income Attributable to Non-
                    controlling Interest                                                                16                                                    5                       25                  9





                   Net Loss Attributable to
                    Stockholders of Inpixon                                            $
              (7,467)                                 $
              (6,584)        $
          (20,944)   $
         (16,969)





      Deemed dividend for triggering of
       warrant down round feature                                                                                                                                                                (1,250)



                   Net Loss Attributable to Common
                    Stockholders                                                       $
              (7,467)                                 $
              (6,584)        $
          (20,944)   $
         (18,219)





                   Net Loss Per Share -Basic and
                    Diluted                                                             $
              (0.18)                                 $
              (12.68)          $
          (0.90)    $
         (65.89)





                   Weighted Average Shares
                    Outstanding



     Basic and Diluted                                                                         41,544,961                                              519,257               23,203,004            276,499







                   Comprehensive Loss



     Net Loss                                                                         $
              (7,451)                                 $
              (6,579)        $
          (20,919)   $
         (16,960)


      Unrealized foreign exchange gain/
       (loss) from cumulative
       translation adjustments                                                                          70                                                 (67)                   (225)              (36)



                   Comprehensive Loss                                                  $
              (7,381)                                 $
              (6,646)        $
          (21,144)   $
         (16,996)


                                                    
         
                INPIXON AND SUBSIDIARIES


                                         
              
           CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS


                                                      
            
                (In thousands)

                                                                      ---



                                                             For the Nine Months Ended


                                                        
              September 30,



                                                                                  2020                           2019



                               
              (Unaudited)




                   Cash Flows Used In Operating
                    Activities



       Net loss                                                                            $
              (20,919)      $
        (16,960)


      Adjustments to reconcile net
       loss to net cash used in
       operating activities:


      Depreciation and amortization                                                                          568                  826


      Amortization of intangible
       assets                                                                                              1,929                2,602


      Amortization of right of use
       asset                                                                                                 322                  267


      Stock based compensation                                                                               941                2,618


      Amortization of technology                                                                                                  50


      Loss on exchange of debt for
       equity                                                                                                132                  188


      Amortization of debt discount                                                                        2,272                1,543


      Accrued interest income, related
       party                                                                                                (32)


      Provision for doubtful accounts                                                                                            358


      Provision for the valuation
       allowance held for sale loan                                                                        1,514


      Provision for the valuation
       allowance related party
       receivable                                                                                            648



     Income tax benefit                                                                                    (87)                (35)



     Other                                                                                                   74                   23




      Changes in operating assets and
       liabilities:


      Accounts receivable and other
       receivables                                                                                       (1,111)             (1,241)



     Inventory                                                                                             (14)               (194)



     Other current assets                                                                                 (814)                (45)



     Other assets                                                                                          (20)               (284)



     Accounts payable                                                                                   (1,359)               1,140



     Accrued liabilities                                                                                     54                   56



     Deferred revenue                                                                                       224                (369)


      Operating lease liabilities                                                                          (325)



     Other liabilities                                                                                      453                  400




     Total Adjustments                                                                                    5,369                7,903



                   Net Cash Used in Operating
                    Activities                                                                          (15,550)             (9,057)




                   Cash Flows Used in Investing
                    Activities


         Purchase of property and
          equipment                                                                                        (546)                (58)


      Investment in capitalized
       software                                                                                            (688)               (658)


      Cash paid for the acquisition of
       Jibestream                                                                                                            (3,714)


      Cash paid for the acquisition of
       GTX                                                                                                                     (250)


      Cash paid for the acquisition of
       Locality                                                                                                                (204)


      Cash paid for the Systat
       Licensing Agreement                                                                               (2,200)


      Cash paid for the acquisition of
       Ten Degrees                                                                                       (1,500)



                   Net Cash Flows Used in Investing
                    Activities                                                                           (4,934)             (4,884)




                   Cash Flows From Financing
                    Activities


      Net (repayments) proceeds to
       bank facility                                                                                       (150)                 237


      Net proceeds from issuance of
       common stock, preferred stock
       and warrants                                                                                                           14,791


      Net proceeds from issuance of
       common stock                                                                                       44,041


      Net repayments of notes payable                                                                       (74)                (71)


      Loans to related party                                                                             (1,806)             (9,866)


      Advances to related party                                                                                                 (15)


      Repayments from related party                                                                          292                1,683



     Loan to Jibestream                                                                                                       (141)



     Loan to GTX                                                                                                               (50)


      Net proceeds from promissory
       notes                                                                                               5,000                6,750


      Repayment of acquisition
       liability to Locality
       shareholders                                                                                        (250)



                   Net Cash Provided By Financing
                    Activities                                                                            47,053               13,318




                   Effect of Foreign Exchange Rate
                    on Changes on Cash                                                                      (42)                (36)




                   Net Increase (Decrease) in Cash,
                    Cash Equivalents and Restricted
                    Cash                                                                                  26,527                (659)




      Cash, Cash Equivalents and
       Restricted Cash -Beginning of
       period                                                                                              4,849                1,224





      Cash, Cash Equivalents and
       Restricted Cash -End of period                                                         $
              31,376         $
           565



       
                Reconciliation of Non-GAAP Financial Measures:







       (In thousands)                                                        For the Three Months Ended                   For the Nine Months Ended

    ---

                              
              
                September 30,                                          September 30,

                                               ---

                                                                    2020                       2019                  2020               2019



        Net loss attributable to common stockholders                     $
        (7,467)                   $
         (6,584)                     $
            (20,944)   $
      (18,219)



       Adjustments:



       Non-recurring one-time charges:



       Loss on exchange of debt for equity                                                                          27                                     132             188


        Provision for valuation allowance on held for
         sale loan                                                                 679                                                                    1,514


        Provision for the valuation allowance related
         party receivable                                                                                                                                  648



       Settlement of litigation                                                                                                                                            6


        Acquisition transaction/financing costs                                    344                               573                                     540           1,220


        Costs associated with public offering                                                                                                                              50



       Severance                                                                                                    26                                                    126



       Bad debts expense/provision                                                444                               253                                     444             358


        Deemed dividend for triggering of warrant down
         round feature                                                                                                                                                  1,250


        Stock-based compensation - compensation and
         related benefits                                                          256                               871                                     941           2,618



       Interest expense, net                                                      537                             1,190                                   1,934           2,054



       Depreciation and amortization                                              589                             1,268                                   2,497           3,428



       Income tax benefit                                                                                         (33)                                   (87)           (35)




       Adjusted EBITDA                                                  $
        (4,618)                   $
         (2,409)                     $
            (12,381)    $
      (6,956)










       (In thousands, except share data)                                     For the Three Months Ended                   For the Nine Months Ended

    ---

                              
              
                September 30,                                          September 30,

                                               ---

                                                                    2020                       2019                  2020               2019



        Net loss attributable to common stockholders                     $
        (7,467)                   $
         (6,584)                     $
            (20,944)   $
      (18,219)



       Adjustments:



       Non-recurring one-time charges:



       Loss on exchange of debt for equity                                                                          27                                     132             188


        Provision for valuation allowance on held for
         sale loan                                                                 679                                                                    1,514


        Provision for the valuation allowance related
         party receivable                                                                                                                                  648



       Settlement of litigation                                                                                                                                            6


        Acquisition transaction/financing costs                                    344                               573                                     540           1,220


        Costs associated with public offering                                                                                                                              50



       Severance                                                                                                    26                                                    126



       Bad debts expense/provision                                                444                               253                                     444             358


        Deemed dividend for triggering of warrant down
         round feature                                                                                                                                                  1,250


        Stock-based compensation - compensation and
         related benefits                                                          256                               871                                     941           2,618



       Amortization of intangibles                                                288                               969                                   1,811           2,602



       Proforma non-GAAP net loss                                            $(5,456)                         $(3,865)                              $(14,914)       $(9,801)



        Proforma non-GAAP net loss per basic and
         diluted common share                                                  $(0.13)                    $
         (7.44)                                $(0.64)    $
      (35.45)



        Weighted average basic and diluted common
         shares outstanding                                                 41,544,961                           519,257                              23,203,004         276,499

View original content to download multimedia:http://www.prnewswire.com/news-releases/inpixon-reports-third-quarter-2020-financial-results-and-provides-corporate-update-301172351.html

SOURCE Inpixon